Measurement of broadband temperature-dependent ultrasonic attenuation and dispersion using photoacoustics.

The broadband ultrasonic characterization of biological fluids and tissues is important for the continued development and application of high-resolution ultrasound imaging modalities. Here, a photoacoustic technique for the transmission measurement of temperature-dependent ultrasonic attenuation and dispersion is described. The system uses a photoacoustic plane wave source constructed from a polymethylmethacrylate substrate with a thin optically absorbent layer. Broadband ultrasonic waves are generated by illuminating the absorbent layer with nanosecond pulses of laser light. The transmitted ultrasound waves are detected by a planar 7-microm high-finesse Fabry-Perot interferometer. Temperature-induced thickness changes in the Fabry-Perot interferometer are tracked to monitor the sample temperature and maintain the sensor sensitivity. The measured -6 dB bandwidth for the combined source and sensor is 1 to 35 MHz, with an attenuation corrected signal level at 100 MHz of -10 dB. The system is demonstrated through temperature-dependent ultrasound measurements in castor oil and olive oil. Power law attenuation parameters are extracted by fitting the experimental attenuation data to a frequency power law while simultaneously fitting the dispersion data to the corresponding Kramers-Krönig relation. The extracted parameters are compared with other calibration measurements previously reported in the literature.

Prevention of fatal arrhythmias in high-risk subjects by fish oil n-3 fatty acid intake.

BACKGROUND: The long-chain n-3 fatty acids in fish have been demonstrated to have antiarrhythmic properties in experimental models and to prevent sudden cardiac death in a randomized trial of post-myocardial infarction patients. Therefore, we hypothesized that these n-3 fatty acids might prevent potentially fatal ventricular arrhythmias in high-risk patients. METHODS AND RESULTS: Four hundred two patients with implanted cardioverter/defibrillators (ICDs) were randomly assigned to double-blind treatment with either a fish oil or an olive oil daily supplement for 12 months. The primary end point, time to first ICD event for ventricular tachycardia or fibrillation (VT or VF) confirmed by stored electrograms or death from any cause, was analyzed by intention to treat. Secondary analyses were performed for "probable" ventricular arrhythmias, "on-treatment" analyses for all subjects who had taken any of their oil supplements, and "on-treatment" analyses only of those subjects who were on treatment for at least 11 months. Compliance with double-blind treatment was similar in the 2 groups; however, the noncompliance rate was high (35% of all enrollees). In the primary analysis, assignment to treatment with the fish oil supplement showed a trend toward a prolonged time to the first ICD event (VT or VF) or of death from any cause (risk reduction of 28%; P=0.057). When therapies for probable episodes of VT or VF were included, the risk reduction became significant at 31%; P=0.033. For those who stayed on protocol for at least 11 months, the antiarrhythmic benefit of fish oil was improved for those with confirmed events (risk reduction of 38%; P=0.034). CONCLUSIONS: Although significance was not achieved for the primary end point, this study provides evidence that for individuals at high risk of fatal ventricular arrhythmias, regular daily ingestion of fish oil fatty acids may significantly reduce potentially fatal ventricular arrhythmias.